Silexion Completes Data Collection Phase in First-Ever Evaluation of SIL-204 in Clinically Relevant Orthotopic Models; ...
"This effect is particularly pronounced in women, who already experience higher rates of cognitive impairment after menopause," added Christmas, who was not involved in the initial study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback